New: a trial court in 1 of every 10 U.S. counties. Read the post
Court Rules
All enforcement actions
CoalitionLow RiskMultistate

Coalition of AGs Opposes EPA Rollback of PFAS Manufacturer Reporting Rules

PFAS Manufacturers and ImportersDecember 22, 2025Connecticut Attorney General

Summary

Attorney General William Tong led a coalition of 15 attorneys general in submitting a comment letter to the EPA opposing the Trump Administration's proposal to roll back PFAS reporting requirements under the Toxic Substances Control Act. The coalition argues that the exemptions would shield most manufacturers from reporting critical information about PFAS chemicals, hindering efforts to protect public health and the environment.

Contract Impact

In-house legal teams should review contracts with manufacturers, importers, and suppliers to ensure they include provisions for PFAS reporting and compliance with TSCA requirements. Key clauses to check include chemical disclosure obligations, environmental warranties, audit rights, and indemnification for PFAS-related liabilities.

Contract Search Terms

PFAS reportingTSCA compliancechemical disclosureforever chemicalsenvironmental clausessupplier obligationsdata reporting requirementsmanufacturer responsibilitiesimport verificationhealth and safety data

Laws Cited

Toxic Substances Control ActAdministrative Procedure Act

Violation Types

Entity Details

Entity

PFAS Manufacturers and Importers

Also known as: PFAS Manufacturers

Industry

Other

Multistate Coalition

IllinoisCaliforniaHawaiiMarylandMassachusettsMichiganMinnesotaNew JerseyNew YorkNorth CarolinaOregonRhode IslandWashingtonWisconsin

Official Sources

Source Evidence

Entity Name
"manufacturers and importers of PFAS"
Laws Cited
"Toxic Substances Control Act"
Laws Cited
"APA"
Violation Types
"shield from reporting over 98 percent of entities"

Related Enforcement Actions

CT

Frontier Communications Parent Inc.

$625K

Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.

CT

Boston Children’s Health Physicians and XTIUM

$2.6M

Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.

CT

Character Technologies, Inc.

Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.

CT

Connecticut public utilities

Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.

CT

RZ Smoke, Inc.

$2.0M

Connecticut Attorney General William Tong announced a settlement with RZ Smoke, Inc. over allegations that it distributed and sold high-potency cannabis products without a state license. The stipulated judgment is $2 million, with $375,000 payable to the State and $1.6 million suspended to ensure compliance; the company is barred from specified cannabis activities in Connecticut unless licensed.

CT

Takeda Pharmaceuticals, U.S.A., Inc.

$13.7M

Connecticut joined a coalition of states and the federal government in settling allegations that Takeda paid healthcare providers speaker honoraria and provided meals to induce prescriptions of Trintellix, leading to allegedly false claims to government healthcare programs. Takeda agreed to pay $13,670,921 plus accrued interest, with portions allocated to federal and state programs.